Laboratory Medicine

Test Directory / Infliximab (Remsima / Remicade)

Infliximab (Remsima / Remicade)

Brown clotted serum, gel barrier

Test	Infliximab (Remsima / Remicade)
Common Abbreviations	INFLIX
Profile	NA
Tube type	Brown clotted serum, gel barrier
Clinical Indication	Measurement is a useful tool in managing patients who fail to respond or who go on to lose response to treatment. It is a chimeric monoclonal antibody which specifically targets TNF?.
Specimen Type	Blood
Sample type	Serum
Minimum Volume	1mL
Special Precautions	No special requirements
Stability	Contact Referral Laboratory
Turnaround Time	10 working days
Laboratory	Napp Pharmaceuticals Limited funds the provision of the Remsima ® testing services provided by Exeter Clinical Laboratories International. This service is only available to healthcare professionals for use with patients who have been prescribed Remsima. https://www.exeterlaboratory.com/requestor-login/
Reference Interval	Contact Referral Laboratory
Limitations	Contact Referral Laboratory
Notes

Update for visitors

Visiting restrictions are in place at our hospitals to stop the spread of norovirus. These restrictions will be in place until further notice.

The following wards are closed to visitors:

York Hospital: Ward 29 and Ward 37.

There are four exceptions only to the restrictions. These are:

For patients who are receiving end of life care

Paediatric patients (babies and children)

Maternity care

The family carers of those with dementia

We understand these restrictions can be difficult when a loved one is unwell. The restrictions will be reviewed daily and lifted as soon as it is safe. Thank you for your understanding as we try to reduce the spread of norovirus in our hospitals.